Resources
Filter by Topic
- Resource Hubs
Finding Rare Disease Patients with Real-World Data and Analytics
- Articles
by Ragib Ahsan, Erik Maul, Eric Girouard, April Duddy, and Srini Raghavan
- Blogs
Accessing real-world data across international borders has long been a headache for life sciences companies. Data residency laws, privacy concerns, and siloed systems have historically...
- Press Releases
Exploratory data tool and Gen AI-powered assistant help life sciences teams unlock deeper RWD insights
- Press Releases
Boston, MA - May 8, 2025 - Panalgo, a Norstella company dedicated to revolutionizing healthcare data analytics, announced today that Instant Health Data (IHD) Cloud,...
- Blogs
Accessing and leveraging real-world data (RWD) is a persistent challenge for life sciences companies. Data silos, inefficiencies, and complex workflows often hinder organizations from fully...
Pregnancy rates and outcomes in women with and without MS in the United States
Authors: MK Houtchens, NC Edwards, G Schneider, K Stern, AL Phillips Published: Neurology, 2018. Click here for the article.
Cost-effectiveness analysis of erenumab for the preventive treatment of episodic and chronic migraine: Results from the US societal and payer perspectives
Authors: Matthew Sussman, Jennifer Benner, Peter Neumann, Joseph Menzin Published: Cephalalgia, 2018. Click here for the full article.
Predictors of All-Cause Healthcare Payments Among Patients with Treatment-Resistant Major Depressive Disorder
Authors: M Sussman, A O’Sullivan, A Shah, J Menzin, M Olfson Published: Value in Health, ISPOR 2018 Click here for the article.
Real-World Bleeding Risks in Non-Valvular Atrial Fibrillation Patients with Heart Failure: Contemporary HER Results Among Prescribed Apixaban, Dabigatran, Rivaroxaban, and Warfarin.
Authors: Iris Lin, Ruslan Horblyuk, Jack Mardekian, Sang Hee Park, Shital Kamble, Melissa Hamilton, Younos Abdulsattar, William Petkun, Joseph Menzin, and Gregory Y Lip Published: Circulation,
Comorbidity in US patients with multiple sclerosis
Authors: N Edwards, M Munsell, J Menzin, A Phillips Published: Patient Related Outcome Measures, 2018 Click here to view.
Development and validation of a claims-based measure as an indicator for disease severity in patients with multiple sclerosis treated with disease-modifying drugs
Authors: Michael Munsell, Molly Frean, Joseph Menzin, and Amy L. Phillips Published: BMC Neurology Click here for the article.
IHD Analytics
Put reliable, rapid analytics in the hands of more people across your organization